Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Y S Milovanov"'
Autor:
L V Kozlovskaya, Y S Milovanov, M V Taranova, Artyom Gil, T V Androsova, M V Lebedeva, G G Kiyakbaev, L Y Milovanova, I V Rogova, Mukhin Na, Svetlana Milovanova
Publikováno v:
Annals of the Russian academy of medical sciences. 71:288-296
Objective: to determine the role of serum Klotho (s-Klotho) protein levels changes in patients with different stages of chronic kidney disease (CKD). Methods: The study involved 130 patients with CKD stages 1–5D (mean age ― 41±6.7 years). Serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b675e8860c2f343104f7ad1f137d27a
https://doi.org/10.15690/vramn581
https://doi.org/10.15690/vramn581
Autor:
Vladimir Reshetnikov, Sergey Moiseev, Vasiliy Kozlov, Lidia Lysenko, M V Lebedeva, Y S Milovanov, M V Taranova, Victor Fomin, Svetlana Milovanova, Lyudmila Milovanova, Elena Kozevnikova
Publikováno v:
Clinical and experimental nephrology. 22(6)
A low protein diet (LPD) with essential amino acid ketoanalogue supplementation (KA) may contribute in improving of chronic kidney disease (CKD), while the exact mechanisms of KA’s effect are not established yet. We have conducted a prospective, ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0299d3d1af3f419e16d22cf77e60da42
https://pubmed.ncbi.nlm.nih.gov/29948444
https://pubmed.ncbi.nlm.nih.gov/29948444
Publikováno v:
Терапевтический архив, Vol 88, Iss 6, Pp 95-100 (2016)
The review considers the current views of the mechanisms of hyperphosphatemia in patients with chronic renal failure. It shows indications for the use of different classes of phosphate-binding drugs to correct hyperphosphatemia.В обзоре рас
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e80f1101be7bad4db30eb5db955f6c5
https://pubmed.ncbi.nlm.nih.gov/27489902
https://pubmed.ncbi.nlm.nih.gov/27489902
Publikováno v:
Terapevticheskii arkhiv. 88:21
To investigate the impact of anemia correction with erythropoiesis stimulants on the serum level of the circulating morphogenetic protein α-Klotho in patients with Stages 3B--4 chronic kidney disease (CKD).64 patients aged 42±8 years with Stages 3B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c2fce356e53ffc01f36b9cd98e3f5a
https://doi.org/10.17116/terarkh201688621-25
https://doi.org/10.17116/terarkh201688621-25
Autor:
Sergey Moiseev, Mukhin Na, L Y Milovanova, Markina Mm, Kudryavtseva Dv, Andrey A. Svistunov, L V Kozlovskaya, V V Fomin, V. D. Beketov, M V Lebedeva, Svetlana Milovanova, Y S Milovanov
Publikováno v:
Europe PubMed Central
AIM. To analyze changes in the serum concentrations of the morphogenetic proteins fibroblast growth factor 23 (FGF-23) and Klotho, as well as sclerostin, an osteocyte-secreted glycoprotein, in relation to the degree of hypertension, left ventricular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435aa261cb47f008357d0db176e1faaf
http://europepmc.org/abstract/med/26281189
http://europepmc.org/abstract/med/26281189
